Clinical research
Congruence of the current practices in Hymenoptera venom allergic patients in Poland with EAACI guidelines
 
More details
Hide details
 
Submission date: 2010-09-04
 
 
Final revision date: 2010-10-23
 
 
Acceptance date: 2010-10-26
 
 
Online publication date: 2011-11-08
 
 
Publication date: 2011-11-08
 
 
Arch Med Sci 2011;7(5):832-839
 
KEYWORDS
TOPICS
ABSTRACT
Introduction : Venom immunotherapy (VIT) practice is the definitive treatment for patients with potentially fatal allergic reactions to Hymenoptera stings. The aim is assesing compliance of VIT practice in Poland with the current European Academy of Allergy and Clinical Immunology (EAACI) guidance.
Material and methods : A multicentre study was carried out using a structured questionnaire which was sent by post to all VIT practitioners in Poland. Some questionnaire items were altered, in comparison to original version by adding additional answer options or alowing multiple answer option. The response rate was 100%. The obtained results were compared with the published EAACI guidelines.
Results : Twenty-six Polish centres took part in the survey. SSIgE and skin prick tests (SPT) are together used as the first line of investigation, whereas confirmatory intradermal tests (IDT) are applied in half of centres. Only a few centres measure baseline serum tryptase levels. The ultra-rush protocol is preferred. Antihistamine pre-medication is routinely practiced. A target dose equal to 100 µg is used in most centres. A 6-week interval between booster doses is the most frequent. Five years is considered as an optimal VIT duration. Before the VIT completion, SSIgE is evaluated in fifty percent of centres, whereas sting challenge is considered by half of responders.
Conclusions : There are some differences between current practice in Poland and the EAACI recommendations, indicating areas requiring better compliance. Comparision between Poland and the United Kingdom revealed that health service organization and health care funding may play a major role in the provision of allergy services. This may affect the extent to which international guidance may be applied in individual countries. It is worth considering conducting the same survey in other European countries.
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top